These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. Zardi EM; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Frego M; Afeltra A; Lumachi F In Vivo; 2006; 20(3):377-80. PubMed ID: 16724674 [TBL] [Abstract][Full Text] [Related]
3. Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications. Zardi EM; Picardi A; Fazio VM; Ambrosino G; Dobrina A; Zullo M; Zennaro D; Afeltra A J Interferon Cytokine Res; 2004 May; 24(5):297-300. PubMed ID: 15153313 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy. Zardi EM; Picardi A; Ambrosino G; Serio A; Costantino S; Dobrina A Ultrasound Med Biol; 2003 Feb; 29(2):209-13. PubMed ID: 12659908 [TBL] [Abstract][Full Text] [Related]
5. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III. Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559 [TBL] [Abstract][Full Text] [Related]
6. [Quantitative evaluation of flow in the portal vein. Comparison of bolus tracking magnetic resonance and Doppler color ultrasound]. Manfredi R; Scarano E; Barbaro B; Prudenzano R; Marano P Radiol Med; 1997 Dec; 94(6):626-31. PubMed ID: 9524601 [TBL] [Abstract][Full Text] [Related]
7. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication. Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235 [TBL] [Abstract][Full Text] [Related]
8. [Study of vascular access (VA) by color Doppler ultrasonography (CDU). Comparison between delta-H and CDU methods in measuring VA blood flow rate]. Roca-Tey R; Rivas A; Samon R; Ibrik O; Viladoms J Nefrologia; 2005; 25(6):678-83. PubMed ID: 16514909 [TBL] [Abstract][Full Text] [Related]
9. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension]. Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727 [TBL] [Abstract][Full Text] [Related]
11. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study. Deibert P; Schumacher YO; Ruecker G; Opitz OG; Blum HE; Rössle M; Kreisel W Aliment Pharmacol Ther; 2006 Jan; 23(1):121-8. PubMed ID: 16393289 [TBL] [Abstract][Full Text] [Related]
12. Comparison between color Doppler cineloop- and conventional spectral Doppler-derived maximum velocity and flow in the umbilical vein. Gerada M; Struijk PC; Stewart PA; Guerriero S; Melis GB; Wladimiroff JW Ultrasound Obstet Gynecol; 2006 Aug; 28(2):156-61. PubMed ID: 16823891 [TBL] [Abstract][Full Text] [Related]
13. Liver transplant recipients with portal vein thrombosis: a single center retrospective study. Tao YF; Teng F; Wang ZX; Guo WY; Shi XM; Wang GH; Ding GS; Fu ZR Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):34-9. PubMed ID: 19208512 [TBL] [Abstract][Full Text] [Related]
14. [A new infusion method for a prostacyclin analogue]. Pibiri L; Petruzzo P; Angius D; Ruiu G; Polo F; Rescigno A; Brotzu G Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128 [TBL] [Abstract][Full Text] [Related]
15. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia. Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713 [TBL] [Abstract][Full Text] [Related]
16. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study. Danielsson P; Metzsch C; Norgren L Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041 [TBL] [Abstract][Full Text] [Related]
17. Six years' experience with prostaglandin I2 infusion in elective open repair of abdominal aortic aneurysm: a parallel group observational study in a tertiary referral vascular center. Beirne C; Hynes N; Sultan S Ann Vasc Surg; 2008 Nov; 22(6):750-5. PubMed ID: 18992665 [TBL] [Abstract][Full Text] [Related]
18. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients]. Ferlito S; Bonomo T; Costa R; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli M; Mazzone D Minerva Cardioangiol; 1996 Dec; 44(12):645-8. PubMed ID: 9053818 [TBL] [Abstract][Full Text] [Related]
19. Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Kiefer P; Tugtekin I; Wiedeck H; Bracht H; Vogt J; Wachter U; Weiss M; Altin C; Georgieff M; Radermacher P Intensive Care Med; 2001 Jul; 27(7):1179-86. PubMed ID: 11534566 [TBL] [Abstract][Full Text] [Related]
20. [Conservative treatment of chronic obstructive arterial disease with iloprost and physical training: assessment of results in 5 years of a study with 360 patients]. Apperti M; Masella A; Sabia D; Verde I Ann Ital Chir; 2003; 74(4):453-7. PubMed ID: 14971289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]